Advertisement

Topics

Illumina Company Profile

07:46 EDT 20th June 2018 | BioPortfolio

Illumina develops tools for the large-scale analysis of genetic variation and function, the results of which will pave the way for personalized medicine, a key goal of genomics and proteomics. Our technology platform also extends to other applications such as high-throughput screening of pharmaceutical compounds and chemical detection.

Location

9390 Towne Centre Dr. Suite 200
San Diego
CA
92024
United States of America

Contact

Phone: 858 587 4297
Email: investor@illumina.com


News Articles [83 Associated News Articles listed on BioPortfolio]

Illumina -- LATEST 2

Through the BIO-Illumina program, we offer member companies that are first-time Illumina customers exclusive rebates on bench -More- 

A Need for Speed: Illumina Acquires San Diego’s Edico Genome

With the Bio-IT World Conference opening today in Boston, San Diego-based Illumina (NASDAQ: [[ticker:ILMN) said it has acquired Edico Genome, a five-year-old startup with  technology to accelerate th...

Illumina Launches iSeq 100 Sequencing System

Industry-Leading Sequencing Technology for Under $20K SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ: ILMN) announced today the launch of the iSeq™ 100 Sequencing System. The new,...

Illumina -- LATEST 3

Through collaborative innovation, Illumina is fueling groundbreaking advancements in oncology, reproductive health, genetic d -More- 

Bristol-Myers Squibb and Illumina Partner for Companion Diagnostics for Oncology Immunotherapies

NEW YORK & SAN DIEGO–(BUSINESS WIRE)–Bristol-Myers Squibb Company (NYSE: BMY) and Illumina, Inc. (NASDAQ: ILMN) today announced a collaboration that will utilize Illumina’s next-g...

Illumina and Loxo Oncology Join Forces to Develop Pan-Cancer Companion Diagnostics

Illumina is teaming up with Loxo Oncology to develop and commercialize a multi-gene panel for broad cancer profiling. It will seek approval for a version of Illumina’s TruSight Tumor 170 as a compan...

Sequencing-Based Pan-Cancer Companion Diagnostics: Illumina And Loxo Oncology Partner Up

NewsThe co-development partnership will seek approval for a version of the Illumina TruSight Tumor 170 as a companion diagnostic (CDx) for Loxo Oncology’s larotrectinib, which targets NTRK gene fusi...

5 Dinge, die jeder Investor von Illumina wissen sollte

Überrascht es jemanden, dass die Werkzeuge zur Entschlüsselung des menschlichen Genoms ein wachstumsstarkes Geschäft sind? Das sollten keinen überraschen. Illumina (WKN:927079), das weltführende ...

Drugs and Medications [0 Results]

None

PubMed Articles [59 Associated PubMed Articles listed on BioPortfolio]

A Guide to Illumina BeadChip Data Analysis.

The Illumina Infinium BeadChips are a powerful array-based platform for genome-wide DNA methylation profiling at approximately 485,000 (450K) and 850,000 (EPIC) CpG sites across the genome. The platfo...

Illumina library preparation for sequencing the GC-rich fraction of heterogeneous genomic DNA.

Standard Illumina libraries are biased towards sequences of intermediate GC-content. This results in an underrepresentation of GC-rich regions in sequencing projects of genomes with heterogeneous base...

Potential human pathogenic bacteria in five hot springs in Eritrea revealed by next generation sequencing.

Human pathogens can survive and grow in hot springs. For water quality assessment, Escherichia coli or Enterococci are the main thermotolerant enteric bacteria commonly used to estimate the load of pa...

Effect of two seaweed polysaccharides on intestinal microbiota in mice evaluated by illumina PE250 sequencing.

Effect of polysaccharides from two seaweeds, Porphyra haitanensis and Ulva prolifera, on intestinal microbiota in mice was evaluated by illumina PE250 sequencing. Analysis showed significant structura...

Finding Nemo: Hybrid assembly with Oxford Nanopore and Illumina reads greatly improves the Clownfish (Amphiprion ocellaris) genome assembly.

Some of the most widely recognised coral-reef fishes are clownfish or anemonefishes, members of the family Pomacentridae (subfamily: Amphiprioninae). They are popular aquarium species due to their bri...

Clinical Trials [10 Associated Clinical Trials listed on BioPortfolio]

The ILLUMINA Study. (ILLUMINA)

The aim of the prospective, multicentre, single-arm study is to assess safety and efficacy of a drug eluting stent in Nitinol alloy (NiTiDES) in term of vessel patency and composite event-...

Effect of Probiotics on Nasopharyngeal Microbiome of Children With Otitis Media With Effusion

The aim of this study is to investigate whether the microbiota in the upper respiratory tract (nasopharynx, adenoids and middle ear fluid) of otitis media with effusion (OME) patients is c...

Epigenetic Biomarker for Osteosarcoma

hMe-Seal is a low-input whole-genome cell-free 5hmC sequencing method based on selective chemical labeling. It uses β-glucosyltransferase (βGT) to selectively label 5hmC with a biotin vi...

Comprehensive DNA Methylation Profiling in Crohn's Disease

Previous studies have indicated that abnormal DNA methylation frequently occurs in the mucosa in Crohn's disease. Comprehensive DNA methylation profiling of the inflamed and non-inflamed i...

Nutritional Intake and Gut Microbiome

Pediatric obesity has been increasing in prevalence, but concerns have been raised around the world because no treatment has been found. Recently, however, research on gut microbiome has b...

Companies [14 Associated Companies listed on BioPortfolio]

Illumina

Illumina develops tools for the large-scale analysis of genetic variation and function, the results of which will pave the way for personalized medicine, a key goal of genomics and proteomics. Our tec...

Illumina Inc.

Illumina (www.illumina.com) is a leading developer, manufacturer, and marketer of life science tools and integrated systems for the analysis of genetic variation and functi...

GRAIL

GRAIL is focused on detecting cancer at an early-stage, when it can be cured. The company secured over $100 million in Series A financing from Illumina, Inc. and ARCH Venture Part...

Illumina, Inc.

Illumina (www.illumina.com) is a leading developer, manufacturer, and marketer of life science tools and integrated systems for large-scale analysis of genetic variation and ...

bioMérieux & Illumina

More Information about "Illumina" on BioPortfolio

We have published hundreds of Illumina news stories on BioPortfolio along with dozens of Illumina Clinical Trials and PubMed Articles about Illumina for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Illumina Companies in our database. You can also find out about relevant Illumina Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Bioinformatics
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...


Corporate Database Quicklinks



Searches Linking to this Company Record